These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19120353)

  • 1. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
    Finkenstedt A; Bianchi P; Theurl I; Vogel W; Witcher DR; Wroblewski VJ; Murphy AT; Zanella A; Zoller H
    Br J Haematol; 2009 Mar; 144(5):789-93. PubMed ID: 19120353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
    Theurl I; Finkenstedt A; Schroll A; Nairz M; Sonnweber T; Bellmann-Weiler R; Theurl M; Seifert M; Wroblewski VJ; Murphy AT; Witcher D; Zoller H; Weiss G
    Br J Haematol; 2010 Feb; 148(3):449-55. PubMed ID: 19863534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
    Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
    Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF15 expression and iron overload in ineffective erythropoiesis.
    Tanno T; Miller JL
    Rinsho Ketsueki; 2011 Jun; 52(6):387-98. PubMed ID: 21737991
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause.
    Waalen J; von Löhneysen K; Lee P; Xu X; Friedman JS
    Eur J Haematol; 2011 Aug; 87(2):107-16. PubMed ID: 21535154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].
    Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.
    Tamary H; Shalev H; Perez-Avraham G; Zoldan M; Levi I; Swinkels DW; Tanno T; Miller JL
    Blood; 2008 Dec; 112(13):5241-4. PubMed ID: 18824595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of GDF15 on iron overloading and erythropoiesis].
    Zhao YS; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):537-41. PubMed ID: 21518525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
    Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
    Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.
    Frazer DM; Wilkins SJ; Darshan D; Badrick AC; McLaren GD; Anderson GJ
    Br J Haematol; 2012 Jun; 157(5):615-26. PubMed ID: 22449175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
    Tanno T; Bhanu NV; Oneal PA; Goh SH; Staker P; Lee YT; Moroney JW; Reed CH; Luban NL; Wang RH; Eling TE; Childs R; Ganz T; Leitman SF; Fucharoen S; Miller JL
    Nat Med; 2007 Sep; 13(9):1096-101. PubMed ID: 17721544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin is down-regulated in alcohol loading.
    Ohtake T; Saito H; Hosoki Y; Inoue M; Miyoshi S; Suzuki Y; Fujimoto Y; Kohgo Y
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S2-8. PubMed ID: 17331161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.
    Mojzikova R; Koralkova P; Holub D; Zidova Z; Pospisilova D; Cermak J; Striezencova Laluhova Z; Indrak K; Sukova M; Partschova M; Kucerova J; Horvathova M; Divoky V
    Br J Haematol; 2014 May; 165(4):556-63. PubMed ID: 24533562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.
    Casanovas G; Swinkels DW; Altamura S; Schwarz K; Laarakkers CM; Gross HJ; Wiesneth M; Heimpel H; Muckenthaler MU
    J Mol Med (Berl); 2011 Aug; 89(8):811-6. PubMed ID: 21475976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
    Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
    Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron regulation and erythropoiesis.
    Nemeth E
    Curr Opin Hematol; 2008 May; 15(3):169-75. PubMed ID: 18391780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
    Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
    Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.
    Senates E; Yilmaz Y; Colak Y; Ozturk O; Altunoz ME; Kurt R; Ozkara S; Aksaray S; Tuncer I; Ovunc AO
    Metab Syndr Relat Disord; 2011 Aug; 9(4):287-90. PubMed ID: 21417913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.